U.S. Tariffs on 60 Countries Proposed Over Forced Labor

U.S. tariffs on 60 countries would impose 10.0%-12.5% forced-labor duties and could prompt investors to reprice import-cost and supply-chain risk.

June 03, 2026·2 min read
View all news articles
Flat vector of a cargo ship entwined with a tariff band symbolizing U.S. tariffs on 60 countries and supply risk.

KEY TAKEAWAYS

  • USTR proposed across-the-board tariffs on imports from about 60 trading partners.
  • A two-tier schedule would impose 10.0% duties for banned economies and 12.5% for others.
  • The move would replace expiring global levies and elevate import-cost and supply-chain risk for multinationals.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

The Office of the U.S. Trade Representative (USTR) proposed tariffs on imports from 60 countries on June 2–3, 2026, applying a two-tier duty linked to an investigation of goods allegedly made with forced labor. The plan would replace expiring global levies and increase trade risks for multinational companies.

Tariff Proposal and Coverage

The USTR proposal targets imports from about 60 trading partners, including the European Union, the United Kingdom, Canada, Australia, Mexico, and Taiwan. It sets a two-tier tariff schedule: a 10.0% duty for economies that have adopted full or partial prohibitions on forced-labor trade and a 12.5% duty for others. The tariffs would apply broadly across products from most major trading partners rather than focusing on specific sectors.

Legal and Timing Context

The proposal follows a Supreme Court ruling that invalidated the administration’s earlier “reciprocal tariffs” program. Officials present forced-labor authority as a new legal basis for raising duties. The tariffs require completion of USTR’s procedural steps and presidential approval before taking effect. The plan is timed to coincide with the expiration of an existing global tariff levy in late July, effectively rolling over tariff coverage under a new legal rationale.

The measure is an executive-branch trade action under existing authority and does not seek new congressional approval. The announcement has drawn attention from investors and political figures, including former Secretary of State Mike Pompeo, as companies and trading partners evaluate potential supply-chain disruptions and increased import costs.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Intel Stock Surges on Reported Google, Nvidia Foundry Deals

Intel Stock Surges on Reported Google, Nvidia Foundry Deals

Intel stock surges after reports of Google TPU orders and Nvidia tests of Intel's advanced process; lack of filings raises verification risk for traders.

SanDisk Stock Climbs Then Pulls Back After Upgrades

SanDisk Stock Climbs Then Pulls Back After Upgrades

SanDisk stock drew June 8 analyst 12-month target lifts after an April blockbuster quarter; traders weigh May AI gains versus NAND supply concerns.

Ingredion Tate & Lyle Takeover Agreed

Ingredion Tate & Lyle Takeover Agreed

Ingredion Tate & Lyle takeover is an all-cash $3.6 billion offer that preserves dividends, wins 17.1% undertakings and tightens near-term deal certainty.

Amazon Corning Fiber-Optic Deal Adds North Carolina Jobs

Amazon Corning Fiber-Optic Deal Adds North Carolina Jobs

Amazon Corning fiber-optic deal expands U.S. manufacturing and adds 1,000 jobs while positioning Corning as a supplier for Amazon's data centers.

Roche Nurix Deal Advances BTK Program

Roche Nurix Deal Advances BTK Program

Roche Nurix deal sets U.S. co-commercialization and outlines near-term clinical catalysts, with material deal economics that matter to biotech investors.

Campbell Q3 Results: Sales Fall, Profit Rises

Campbell Q3 Results: Sales Fall, Profit Rises

Campbell Q3 results showed sales fell on snacks weakness, profit rose and management reaffirmed fiscal 2026 guidance, keeping focus on margins.